,i  #aafth ,,congress  #ast ,session    
,h4 ,r4 #ddee  ,,in ,,the ,,house ,,of  
,,representatives  ,september #bj1      
#bjai,mr4 ,schrader 7for himself and    
,mr4 ,gianforte7 introduced the         
following bill2 which was referred to   
the ,committee on ,energy and ,commerce1
 and in addition to the ,committee on   
,ways and ,means1 for a period to be    
subsequently determined by the ,speaker1
 in each case for consideration of such 
provisions as fall within the           
jurisdiction of the committee concerned 
,a ,,bill  ,to amend title ,,xviii of   
the ,social ,security ,act to provide   
for a temporary payment increase under  
the ,medicare program for certain       
biosimilar biological products to       
encourage the development and use of    
such products4  #a4 ,short title ,this  
,act may be cited as the ,bolstering    
,innovative ,options to ,save           
,immediately on ,medicines ,act or the  
,,biosim ,act4  #b4 ,temporary increase 
in ,medicare part ,b payment for certain

 biosimilar biological products ,section
 #ahdg;,a7b77#h7 of the ,social         
,security ,act 7#db ,u4,s4,c4           
#aciew-#c;a7b77#h77 is amended--  7#a7  
by redesignating subparagraphs 7,a7 and 
7,b7 as clauses 7i7 and 7ii71           
respectively1 and moving the margin of  
each such redesignated clause #b ems to 
the right2  7#b7 by striking            
product4--,the amount and inserting the 
following3 8product4--  7,a7 ,in general
 ,subject to subparagraph 7,b71 the     
amount  2 and  7#c7 by adding at the end
 the following new subparagraph3  7,b7  
,temporary payment increase  7i7 ,in    
general ,in the case of a qualifying    
biosimilar biological product that is   
furnished during the applicable #e-year 
period for such product1 the amount     
specified in this paragraph for such    
product with respect to such period is  
the sum determined under subparagraph   
7,a71 except that clause 7ii7 of such   
subparagraph shall be applied by        
substituting #h percent for #f percent4 

7ii7 ,applicable #e-year period ,for    
purposes of clause 7i71 the applicable  
#e-year period for a biosimilar         
biological product is-- 7,i7 in the case
 of such a product for which payment was
 made under this paragraph as of        
,december #ca1 #bjai1 the #e-year period
 beginning on ,january #a1 #bjbj2 and   
7,,ii7 in the case of such a product for
 which payment is first made under this 
paragraph during a calendar quarter     
during the period beginning ,january #a1
 #bjbj1 and ending ,december #ca1 #bjbd1
 the #e-year period beginning on the    
first day of such calendar quarter      
during which such payment is first made4
  7iii7 ,qualifying biosimilar          
biological product defined ,for purposes
 of this subparagraph1 the term         
qualifying biosimilar biological product
 means a biosimilar biological product  
described in paragraph 7#a77;,c7 with   
respect to which-- 7,i7 in the case of a
 product described in clause 7ii77,i71  
the average sales price is not more than

 the average sales price for the        
reference biological product2 and       
7,,ii7 in the case of a product         
described in clause 7ii77,,ii71 the     
wholesale acquisition cost is not more  
than the wholesale acquisition cost for 
the reference biological product  4